Biologics/Immunotherapy News

Innovation in asthma and allergy care continued in 2023. Healio’s most popular stories this year covered breakthroughs in immunotherapy treatments for food allergy and revised looks at common treatments for congestion and allergy.

The FDA has accepted a supplemental biologics application for the use of omalizumab to reduce allergic reactions due to accidental exposure in patients aged 1 year and older with at least one food allergy, according to a press release.

HONOLULU — Patients with well-controlled asthma who use dupilumab may tolerate a reduction in the frequency of their doses from every 2 weeks to every 4 weeks, according to a poster presented at the CHEST Annual Meeting.

Sleep improved for patients with chronic rhinosinusitis with nasal polyps after a month of treatment with dupilumab, according to a study published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in November.

ANAHEIM, Calif. — Children with allergies to multiple foods achieved desensitization with a multi-food oral immunotherapy, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The FDA has granted fast track designation to ADP101, an oral immunotherapy designed to simultaneously treat one or more of the most common food allergies, Alladapt Immunotherapeutics announced in a press release.

ANAHEIM, Calif. — Parents of toddlers with peanut allergy are eager to them get oral immunotherapy, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — ChatGPT answered accurately or somewhat accurately 91% of the time when asked about 10 allergy myths, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — “There are a lot of interesting trends,” John J. Oppenheimer, MD, FACAAI, clinical professor at UMDNJ Rutgers, told Healio at the American College of Allergy, Asthma & Immunology 2023 Annual Scientific Meeting.